
Insider and congress filings
ResMed Inc. (RMD)
NYSE · Healthcare · 328 insider filings · 51 congress trades · last filed yesterdayS&P 500
About ResMed Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Michael J. Farrell
- Employees
- 11,370
- Listed since
- Jun 2, 1995
- Market value
- $31.9B
- Price to earnings
- 21.1
- Earnings per share
- $10.53
- Dividend yield
- 1.12%
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q4 FY2026reported Aug 6, 2026 | $2.95 | $2.89 | $1.5B | $1.5B | EPS beatRevenue in line |
| Q3 FY2026reported Apr 30, 2026 | $2.86 | $2.80 | $1.4B | $1.4B | EPS beatRevenue in line |
| Q2 FY2026reported Jan 29, 2026 | $2.81 | $2.74 | $1.4B | $1.4B | EPS beatRevenue beat |
| Q1 FY2026reported Oct 30, 2025 | $2.55 | $2.51 | $1.3B | $1.3B | EPS beatRevenue in line |
| Q4 FY2025reported Jul 31, 2025 | $2.55 | $2.46 | $1.3B | $1.3B | EPS beatRevenue in line |
| Q3 FY2025reported Apr 23, 2025 | $2.37 | $2.38 | $1.3B | $1.3B | EPS in lineRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $2.4B | 12,317,194 | +1.8% | 8.51% |
| Vanguard Capital Management LLC | $1.8B | 9,474,129 | +0.1% | 6.55% |
| Vanguard Portfolio Management LLC | $1.5B | 7,913,661 | +0.6% | 5.47% |
| State Street Corp | $1.3B | 6,680,735 | +0.6% | 4.62% |
| Geode Capital Management, LLC | $845.2M | 4,352,320 | -0.0% | 3.01% |
| Bank Of New York Mellon Corp | $818.0M | 4,197,610 | -14.8% | 2.90% |
| First Trust Advisors LP | $444.1M | 2,278,696 | +48.2% | 1.57% |
| Invesco Ltd. | $402.1M | 2,063,578 | +5.5% | 1.43% |
| Morgan Stanley | $375.9M | 1,928,931 | -28.2% | 1.33% |
| Northern Trust Corp | $330.6M | 1,696,674 | -1.7% | 1.17% |
| Nordea Investment Management Ab | $269.6M | 1,388,008 | +34.3% | 0.96% |
| Deutsche Bank Ag\ | $257.7M | 1,322,313 | -7.1% | 0.91% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Open-market insider trades
20 filings of 328 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Michael J. FarrellChairman and CEO | Sold · scheduled | 4,991 | $222.44 | $1.1M | Sep 8, 2026 | 2d |
| Peter C. FarrellDirector | Sold | 970 | $234.73 | $228K | Sep 2, 2026 | 2d |
| Michael J. FarrellChairman and CEO | Sold | 4,991 | $205.69 | $1.0M | Aug 7, 2026 | 4d |
| Peter C. FarrellDirector | Sold | 8,000 | $225.00 | $1.8M | Aug 5, 2026 | 1d |
| Michael J. FarrellChairman and CEO | Sold | 4,991 | $218.55 | $1.1M | Jul 7, 2026 | 2d |
| Michael J. FarrellChairman and CEO | Sold | 4,991 | $193.96 | $968K | Jun 8, 2026 | 1d |
| Michael J. FarrellChairman and CEO | Sold | 4,991 | $207.82 | $1.0M | May 7, 2026 | 4d |
| Michael J. FarrellChairman and CEO | Sold | 4,991 | $225.50 | $1.1M | Apr 7, 2026 | 2d |
| Brett SandercockChief Financial Officer | Sold | 1,000 | $224.31 | $224K | Apr 1, 2026 | 2d |
| Peter C. FarrellDirector | Sold | 2,000 | $225.00 | $450K | Apr 1, 2026 | 1d |
| Michael J. FarrellChairman and CEO | Sold | 4,991 | $251.03 | $1.3M | Mar 9, 2026 | 2d |
| Peter C. FarrellDirector | Sold | 2,000 | $260.22 | $520K | Mar 4, 2026 | 1d |
| Brett SandercockChief Financial Officer | Sold | 1,000 | $254.30 | $254K | Mar 2, 2026 | 1d |
| Michael J. FarrellChairman and CEO | Sold | 4,991 | $273.78 | $1.4M | Feb 9, 2026 | 1d |
| Peter C. FarrellDirector | Sold | 2,000 | $251.31 | $503K | Feb 4, 2026 | 2d |
| Michael J. RiderGlobal General Counsel | Sold | 50 | $260.00 | $13K | Feb 4, 2026 | 2d |
| Brett SandercockChief Financial Officer | Sold | 1,000 | $257.03 | $257K | Feb 2, 2026 | 1d |
| Peter C. FarrellDirector | Sold | 2,000 | $248.83 | $498K | Jan 7, 2026 | 2d |
| Michael J. FarrellChairman and CEO | Sold | 4,991 | $248.46 | $1.2M | Jan 7, 2026 | 1d |
| Brett SandercockChief Financial Officer | Sold | 1,000 | $241.75 | $242K | Jan 2, 2026 | 3d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in RMD
20 disclosures of 51 on record · median 17d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +2.2%S&P +0.6% · vs S&P 500 +1.6% | Aug 3, 2026 | Sep 4, 2026 | 32d |
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | -0.2%S&P +20.2% · vs S&P 500 -20.5% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +13.4%S&P +1.6% · vs S&P 500 +11.8% | Jun 16, 2026 | Jul 6, 2026 | 20d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +12.9%S&P +2.1% · vs S&P 500 +10.8% | Jun 30, 2026 | Jul 6, 2026 | 6d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +6.7%S&P +1.6% · vs S&P 500 +5.1% | May 27, 2026 | Jun 9, 2026 | 13d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +7.3%S&P +5.8% · vs S&P 500 +1.5% | May 1, 2026 | Jun 9, 2026 | 39d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +9.0%S&P +3.2% · vs S&P 500 +5.8% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -4.5%S&P +11.1% · vs S&P 500 -15.6% | Apr 13, 2026 | May 11, 2026 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +0.1%S&P +6.8% · vs S&P 500 -6.7% | Apr 24, 2026 | May 11, 2026 | 17d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -3.5%S&P +16.0% · vs S&P 500 -19.5% | Mar 23, 2026 | Apr 7, 2026 | 15d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | 0.0%S&P +20.7% · vs S&P 500 -20.7% | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -12.6%S&P +10.9% · vs S&P 500 -23.4% | Feb 24, 2026 | Mar 9, 2026 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -12.8%S&P +10.6% · vs S&P 500 -23.4% | Jan 23, 2026 | Feb 6, 2026 | 14d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -11.4%S&P +10.9% · vs S&P 500 -22.3% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Kelly Morrison | Stock | Sale | $1,001 - $15,000 | -12.2%S&P +28.2% · vs S&P 500 -40.4% | Jun 4, 2025 | Jun 18, 2025 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -10.1%S&P +29.7% · vs S&P 500 -39.9% | May 28, 2025 | Jun 10, 2025 | 13d |
| Kelly Morrison | Stock | Sale | $1,001 - $15,000 | -6.3%S&P +38.6% · vs S&P 500 -44.9% | Apr 28, 2025 | May 13, 2025 | 15d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +2.6%S&P +42.4% · vs S&P 500 -39.9% | Apr 23, 2025 | May 12, 2025 | 19d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -1.8%S&P +33.7% · vs S&P 500 -35.4% | Mar 6, 2025 | Apr 10, 2025 | 35d |
| Robert BresnahanJoint | Stock | Sale | $1,001 - $15,000 | -4.5%S&P +31.1% · vs S&P 500 -35.6% | Jan 13, 2025 | Feb 13, 2025 | 31d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
3 members · estimate, as of Sep 10, 20263 members report a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Robert Bresnahan | Republican · House | $1,001 - $15,000 | 0.1% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $1,001 - $15,000 | <0.1% |
| Julie Johnson | Democrat · House | $1,001 - $15,000 | 0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Sep 8, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Aug 7, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Jul 7, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Jun 8, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | May 7, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Apr 7, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Mar 9, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Feb 9, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Jan 7, 2026 |
| Michael J. FarrellChairman and CEO | Option exercise | 4,991 | Dec 8, 2025 |
| Michael J. FarrellChairman and CEO | Stock award | 33,288 | Nov 24, 2025 |
| Peter C. FarrellDirector | Stock award | 1,331 | Nov 24, 2025 |
| Nicole Mowad-NassarDirector | Stock award | 1,331 | Nov 24, 2025 |
| John HernandezDirector | Stock award | 1,073 | Nov 20, 2025 |
| Christopher DelOreficeDirector | Stock award | 1,073 | Nov 20, 2025 |
| Michael J. FarrellChairman and CEO | Tax withholding | 7,297 | Nov 20, 2025 |
| Michael J. FarrellChairman and CEO | Stock award | 13,551 | Nov 20, 2025 |
| Brett SandercockChief Financial Officer | Stock award | 2,710 | Nov 20, 2025 |
| Ronald R. TaylorDirector | Stock award | 1,073 | Nov 20, 2025 |
| Carol BurtDirector | Stock award | 1,073 | Nov 20, 2025 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling RMD?
Across the 20 most recent open-market filings shown here, 0 were purchases and 20 were sales. One was scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded RMD?
Ro Khanna, Alan Armstrong, Kelly Morrison, Robert Bresnahan disclosed RMD transactions in the filings shown here.
Which members of Congress hold RMD?
3 members of Congress report a position in RMD in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Robert Bresnahan, Gilbert Ray Cisneros, Jr. and Julie Johnson. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is RMD in the S&P 500 or the Nasdaq 100?
ResMed Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are RMD trades disclosed?
Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 17 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
